跳至主要内容
临床试验/NCT05288426
NCT05288426招募中不适用

Consequences of Post BNT162b2 Vaccine Myocarditis and Multiple Inflammatory Syndrome Myocarditis

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2021年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
To assess troponin levels in patients that developed acute myocarditis

研究概览

简要总结

BNT162b2 vaccine has become one of the most prevalent vaccines against the COVID-19 and is currently the main vaccine used in Israel. Since marketing and the beginning of use of the vaccine, we and others have reported. of the development of post vaccination myocarditis.

In this study the investigators wish to explore the long term impact on 150 patients who have been diagnosed with myocarditis or multisystem inflammatory syndrome (MIS) in the year following their diagnosis of Myocarditis.

详细描述

Aim of Study

The primary aim of the study is to evaluate the impact of long term impact of myocarditis which has been developed secondary to Covid 19 vaccine or Covid 19 infection.

The primary end points of the study will be functional evaluations of the patients using clinical evaluation that includes questionnaires, ECG findings, evaluation of the systolic and diastolic function of the heart using echocardiogram or cardiac MRI, laboratory tests including troponin, CPK, CRP, Pro-BNP, and cytokines/chemokines.

Methods In this prospective study patients will be recruited from health care providers The selected patients will come to Hadassah hospital within 6 and 12 months after they have been diagnosed with myocarditis. Upon the patients arrival they will sign the informed consent, the investigators will draw blood tests and the participants will perform an echocardiogram according to the special protocol and will perform cardiac- MRI according to the myocarditis protocol. Patients will fulfill health questionnaires. that may include 36 Health Survey Questionnaire (SF-36); Scores on the European Quality of Life-5 Dimensions (EQ-5D) survey, which is also health-related quality of life score; the Scores on the European Quality of Life Visual Analogue Scale (EQ-VAS); Kansas City Cardiomyopathy Questionnaire (KCCQ). the Investigators will obtain blood samples from all the patients: complete blood count, c- reactive protein, troponin, CPK, Pro-BNP, liver and kidney functions, magnesium and cytokines. In addition, all participants will undergo echocardiogram test to evaluate their systolic and diastolic function of the heart.

Ethical Considerations

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult males and females.
  • Minors male and female.
  • Diagnosed as myocarditis:
  • Evidence of myocarditis on biopsy or increased biomarkers of myocardial injury (TNI and CK-MB and BNP or NT-pro-BNP)
  • Acute onset of symptoms of cardiac dysfunction: dyspnea, palpation, chest pain, and/or syncope;
  • Image for cardiac injury: marked diffused reduction in left ventricle wall movement, with dramatically decreased left ventricle ejection fraction (LVEF) < 45%, or by cardiac magnetic resonance imaging.

排除标准

  • Also considering acute coronary syndrome but unable to perform coronary angiography to distinguish acute coronary syndrome from myocarditis, or otherwise suffer from valvuloplasty.
  • Myocardial injury caused by sepsis, medical agents, or poisons;
  • Malignancy or any comorbidity limiting survival or conditions predicting inability to complete the study

结局指标

主要结局

To assess troponin levels in patients that developed acute myocarditis

时间窗: 3 years

troponin levels in each clinical visit will be documented

To assess PRO-BNP levels in patients that developed acute myocarditis

时间窗: 3 years

PRO-BNP levels in each clinical visit will be documented

To assess CRP levels in patients that developed acute myocarditis

时间窗: 3 years

CRP levels in each clinical visit will be documented

To assess cardiac MRI in patients that developed acute myocarditis

时间窗: 3 years

Cardiac MRI will be performed at least yearly and evaluated for regionally increased signal in T2-weighted images; Late gadolinium enhancement in a nonischemic pattern, Increased native T1 values on a 3T magnet.

To assess echocardiogram in patients that developed acute myocarditis

时间窗: 3 years

echocardiogram will be performed at least yearly and defined as normal, ST-segment elevation, with Diffuse or Non-diffuse changes, T-wave changes, Atrial fibrillation or non-sustained ventricular tachycardia.

To assess health quality by a questionnaire in patients that developed acute myocarditis

时间窗: 3 years

EQ-5D will be fill at least once a year. Descriptive analysis of EQ-5D profile at each observation and analysis of changes between repeated observations. Cluster analysis can be used.

To assess heart failure questionnaire in patients that developed acute myocarditis

时间窗: 3 years

KCCQ will be fill at least once a year.

次要结局

  • Chemokine in Patients after myocarditis(3 years)
  • Complement in patients after myocarditis(3 years)
  • Cytokine in Patients after myocarditis(3 years)
  • Hematopoietic Growth Factors (HGF)in patients after myocarditis(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mevorach Dror

Professor & Head, Department of Internal Medicine B; Head, Rheumatology Research Center, Hadassah and the Hebrew University Medical School

Hadassah Medical Organization

研究点 (1)

Loading locations...

相似试验